Anna A. Akopyan

588 total citations
34 papers, 394 citations indexed

About

Anna A. Akopyan is a scholar working on Epidemiology, Physiology and Neurology. According to data from OpenAlex, Anna A. Akopyan has authored 34 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Physiology and 10 papers in Neurology. Recurrent topics in Anna A. Akopyan's work include Autophagy in Disease and Therapy (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Alzheimer's disease research and treatments (6 papers). Anna A. Akopyan is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Alzheimer's disease research and treatments (6 papers). Anna A. Akopyan collaborates with scholars based in Russia, Taiwan and Tajikistan. Anna A. Akopyan's co-authors include М. А. Тихонова, А. Б. Пупышев, Н. И. Дубровина, М. В. Тендитник, Tamara G. Amstislavskaya, Т. А. Короленко, T. P. Klyushnik, Sandeep Kumar Singh, Е. К. Хлесткина and Chih‐Li Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Anna A. Akopyan

29 papers receiving 392 citations

Peers

Countries citing papers authored by Anna A. Akopyan

Since Specialization

Citations

This map shows the geographic impact of Anna A. Akopyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna A. Akopyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna A. Akopyan more than expected).

Fields of papers citing papers by Anna A. Akopyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna A. Akopyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna A. Akopyan. The network helps show where Anna A. Akopyan may publish in the future.

Co-authorship network of co-authors of Anna A. Akopyan

This figure shows the co-authorship network connecting the top 25 collaborators of Anna A. Akopyan. A scholar is included among the top collaborators of Anna A. Akopyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna A. Akopyan. Anna A. Akopyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship between the cognitive status of the long-living adults of the Central Federal District of the Russian Federation and socioeconomic factors: analysis of associations 2024 ·(unknown), (unknown), Д. А. Каштанова, (unknown), (unknown), Anna A. Akopyan, V. S. Yudin, В. В. Макаров, Anton А. Keskinov, И. Д. Стражеско, О. Н. Ткачева, (unknown), S. M. Yudin	0
2	Basic Epigenetic Mechanisms of Aging 2023 ·И. Д. Стражеско, (unknown), Anna A. Akopyan, О. Н. Ткачева	2
3	Concordance between the In Vivo Content of Neurospecific Proteins (BDNF, NSE, VILIP-1, S100B) in the Hippocampus and Blood in Patients with Epilepsy 2023 ·International Journal of Molecular Sciences ·М. А. Тихонова, (unknown), (unknown), (unknown), Anna A. Akopyan, (unknown), Konstantin V. Danilenko, Lyubomir I. Aftanas	4
4	Mortality and survival in nonagenarians during the COVID-19 pandemic: Unstable equilibrium of aging 2023 ·Frontiers in Medicine ·Д. А. Каштанова, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), V. S. Yudin, Anna A. Akopyan, И. Д. Стражеско, (unknown), (unknown), В. В. Макаров, О. Н. Ткачева, (unknown), S. M. Yudin	1
5	Brain but not serum BDNF levels are associated with structural alterations in the hippocampal regions in patients with drug-resistant mesial temporal lobe epilepsy 2023 ·Frontiers in Neuroscience ·Elena Filimonova, (unknown), (unknown), (unknown), (unknown), (unknown), Anna A. Akopyan, Konstantin V. Danilenko, Lyubomir I. Aftanas, М. А. Тихонова, (unknown)	8
6	Comparative analysis of early neurodegeneration signs in a mouse model of Alzheimer’s disease-like pathology induced by two types of the central (Intracerebroventricular vs. Intrahippocampal) administration of Aβ25–35 oligomers 2023 ·Behavioural Brain Research ·(unknown), (unknown), М. В. Тендитник, Н. И. Дубровина, Anna A. Akopyan, (unknown), Larisa Fedoseeva, А. Б. Пупышев, Lyubomir I. Aftanas, Tamara G. Amstislavskaya, М. А. Тихонова	3
7	Cognitive impairment in long-living adults: a genome-wide association study, polygenic risk score model and molecular modeling of the APOE protein 2023 ·Frontiers in Aging Neuroscience ·Д. А. Каштанова, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anna A. Akopyan, И. Д. Стражеско, V. S. Yudin, В. В. Макаров, (unknown), О. Н. Ткачева, S. M. Yudin	1
8	Gut Microbiome in Post-COVID-19 Patients Is Linked to Immune and Cardiovascular Health Status but Not COVID-19 Severity 2023 ·Microorganisms ·О. Н. Ткачева, Natalia Klimenko, Д. А. Каштанова, Alexander Tyakht, (unknown), Anna A. Akopyan, (unknown), И. Д. Стражеско	5
9	Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate COVID-19: An observational study 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Daria Fomina, (unknown), Anna A. Akopyan, И. Д. Стражеско, Sergey Lukyanov, О. Н. Ткачева, (unknown), Dmitriy M. Chudakov	10
10	Correlations between vessel stiffness and biomarkers of senescent cell in elderly patients 2022 ·Kardiologiia ·(unknown), Anastasia Efimenko, Olga Grigorieva, (unknown), Nataliya Basalova, (unknown), (unknown), (unknown), И. Д. Стражеско, (unknown), (unknown), L. М. Samokhodskaya, Н. В. Данилова, (unknown), Anna A. Akopyan, (unknown), (unknown), Zhanna Akopyan, Yа. A. Orlova	0
11	Creation of a collection of different biological sample types from elderly patients to study the relationship of clinical, systemic, tissue and cellular biomarkers of accumulation of senescent cells during aging 2022 ·CARDIOVASCULAR THERAPY AND PREVENTION ·(unknown), Yа. A. Orlova, Olga Grigorieva, (unknown), Nataliya Basalova, (unknown), (unknown), (unknown), (unknown), L. М. Samokhodskaya, Н. В. Данилова, (unknown), (unknown), Anna A. Akopyan, (unknown), (unknown), (unknown), Anastasia Efimenko	2
12	Combined induction of mTOR-dependent and mTOR-independent pathways of autophagy activation as an experimental therapy for Alzheimer's disease-like pathology in a mouse model 2022 ·Pharmacology Biochemistry and Behavior ·А. Б. Пупышев, (unknown), М. В. Тендитник, (unknown), Н. И. Дубровина, (unknown), Anna A. Akopyan, Larisa Fedoseeva, Т. А. Короленко, Tamara G. Amstislavskaya, М. А. Тихонова	20
13	Review of polymorphisms, associated with cardiovascular diseases 2021 ·SHILAP Revista de lepidopterología ·Anna A. Akopyan, И. Д. Стражеско, О. Н. Ткачева, (unknown), Yа. A. Orlova	3
14	Restoration of Parkinson’s disease-like deficits by activating autophagy through mTOR-dependent and mTOR-independent mechanisms in pharmacological and transgenic models of Parkinson’s disease in mice 2021 ·Bulletin of Experimental Biology and Medicine ·(unknown), М. В. Тендитник, (unknown), Anna A. Akopyan, Н. И. Дубровина, М. А. Тихонова	0
15	Restoration of Parkinson’s Disease-Like Deficits by Activating Autophagy through mTOR-Dependent and mTOR-Independent Mechanisms in Pharmacological and Transgenic Models of Parkinson’s Disease in Mice 2021 ·Bulletin of Experimental Biology and Medicine ·А. Б. Пупышев, М. В. Тендитник, (unknown), Anna A. Akopyan, Н. И. Дубровина, М. А. Тихонова	11
16	Association of AGT, ACE, NOS3 polymorphism with subclinical arterial wall changes and cardiovascular diseases risk factors. 2020 ·SHILAP Revista de lepidopterología ·Anna A. Akopyan, (unknown), (unknown), (unknown), И. Д. Стражеско, (unknown), (unknown), (unknown)	1
17	Early Parkinson’s Disease-Like Pathology in a Transgenic Mouse Model Involves a Decreased Cst3 mRNA Expression But Not Neuroinflammatory Response in the Brain 2020 ·Т. А. Короленко, (unknown), (unknown), А. Б. Пупышев, Anna A. Akopyan, Larisa Fedoseeva, (unknown), В. А. Вавилин, М. В. Тендитник, Chih‐Li Lin, Tamara G. Amstislavskaya, М. А. Тихонова	5
18	Effects of Grape Polyphenols on the Life Span and Neuroinflammatory Alterations Related to Neurodegenerative Parkinson Disease-Like Disturbances in Mice 2020 ·Molecules ·М. А. Тихонова, (unknown), М. В. Тендитник, (unknown), Anna A. Akopyan, Н. И. Дубровина, Tamara G. Amstislavskaya, Е. К. Хлесткина	22
19	Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease 2018 ·Pharmacology Biochemistry and Behavior ·А. Б. Пупышев, М. А. Тихонова, Anna A. Akopyan, М. В. Тендитник, Н. И. Дубровина, Т. А. Короленко	78
20	Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence 2017 ·Behavioural Brain Research ·М. А. Тихонова, (unknown), Anna A. Akopyan, Н. Г. Колосова, Jun‐Cheng Weng, (unknown), Chih‐Li Lin, Tamara G. Amstislavskaya, Ying‐Jui Ho	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact